Kirsten Nikolajsen

Vaccination with p53-peptide?pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

Inge Marie Svane, Anders Elm Pedersen, Hans Erik Johnsen et al. · Cancer Immunology Immunotherapy · 2004 · 112 citations · Full text

Medicine, Immunology, Oncology +13

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

Inge Marie Svane, Anders Elm Pedersen, Julia S. Johansen et al. · Cancer Immunology Immunotherapy · 2007 · 104 citations · Full text

Medicine, Immunology, Oncology +13

Phenotypic and Functional Characterization of Clinical Grade Dendritic Cells Generated from Patients with Advanced Breast Cancer for Therapeutic Vaccination

Anders Elm Pedersen, Mette Thorn, Monika Gad et al. · Scandinavian Journal of Immunology · 2005 · 56 citations · Full text

Medicine, Cancer Biology, Immunology +14

Different membrane expression of CD11b and CD 14 on blood neutrophils following in <i>vivo</i> administration of myeloid growth factors

Per Boye Hansen, E Kjærsgaard, Hans Erik Johnsen et al. · British Journal of Haematology · 1993 · 33 citations

Life Sciences, Hematology, Immunology +15

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients

Trine Zeeberg Iversen, Marie K. Brimnes, Kirsten Nikolajsen et al. · OncoImmunology · 2013 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16